GeneDx Corp. (WGS)
NASDAQ: WGS
· Real-Time Price · USD
91.61
1.82 (2.03%)
At close: Jul 03, 2025, 3:54 PM
91.17
-0.48%
After-hours: Jul 03, 2025, 04:56 PM EDT
2.03% (1D)
| Bid | 91.17 |
| Market Cap | 2.61B |
| Revenue (ttm) | 330.14M |
| Net Income (ttm) | -38.58M |
| EPS (ttm) | -1.39 |
| PE Ratio (ttm) | -65.91 |
| Forward PE | 44.12 |
| Analyst | Strong Buy |
| Ask | 92.09 |
| Volume | 328,245 |
| Avg. Volume (20D) | 1,182,670 |
| Open | 89.75 |
| Previous Close | 89.79 |
| Day's Range | 88.78 - 92.78 |
| 52-Week Range | 25.32 - 117.75 |
| Beta | 2.01 |
Analyst Forecast
According to 0 analyst ratings, the average rating for WGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
GeneDx Corp. is scheduled to release its earnings on Jul 29, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-42.85%
GeneDx Holdings shares are trading lower. The comp...
Unlock content with
Pro Subscription
4 months ago
+4.93%
GeneDx Holdings shares are trading higher after the company announced an indication expansion for its industry leading genetic testing to now include cerebral palsy.
